Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
HARDEEP SINGH
🇮🇳
India
Country
🇮🇳
India
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Depo-Medrol on Psoas After LLIF
Phase 4
Recruiting
Conditions
Pain, Postoperative
Muscle Weakness
Paresthesia
Pain, Muscle
Interventions
Drug: Gel-Flow NT
Drug: Depo-Medrol
Subscribe
First Posted Date
2023-07-03
Last Posted Date
2023-07-03
Lead Sponsor
Hardeep Singh
Target Recruit Count
80
Registration Number
NCT05929755
Locations
🇺🇸
UConn Health, Farmington, Connecticut, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy